Share
Jack Kenny
OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests and sample management solutions, today announced the election of Jack Kenny to its Board of Directors. With his addition, OraSure’s Board now consists of seven members.
Mr. Kenny, former Chief Executive Officer of Meridian Bioscience, brings over 30 years of leadership experience in the in vitro diagnostics, molecular, and lab services industries. He led the successful turnaround of Meridian Bioscience before its acquisition and will serve as a Class I Director with an initial term set to expire at OraSure’s 2025 Annual Meeting of Stockholders.
“We are excited to strengthen our Board with Jack's expertise and insights,” said Mara Aspinall, Chair of OraSure's Board of Directors. “With the leadership of our President and CEO Carrie Eglinton Manner, we have made significant progress toward strengthening our foundation and accelerating profitability. We look forward to the valuable contributions Jack will bring to further our growth.”
Before his tenure at Meridian, Mr. Kenny held key leadership positions, including Senior Vice President and General Manager of North America at Siemens Healthcare and Vice President and General Manager of the U.S. Region for Becton Dickinson's Diagnostic Systems. He has also held executive roles at Danaher Corporation and Quest Diagnostics.
Mr. Kenny’s operational expertise spans across product management, commercial leadership, and acquisition integration. He holds a bachelor’s degree in management from Kettering University.
